date:May 07, 2012
ociated with a 3.4% reduction in vascular events,wrote Curtis and his colleagues.
Long-term studies are now required to determine whether these effects are restricted to populations of medicated postmenopausal women with established type 2 diabetes and to determine whether chronic intake of flavan-3-ols or isoflavones is as effective when consumed independently,they concluded.